Cargando…

Prognostic value of creatinine-to-cystatin c ratio in patients with type 2 diabetes mellitus: a cohort study

BACKGROUND: The serum creatinine-to-cystatin C ratio (Scr/Scys) has been suggested as a surrogate marker of muscle mass and a predictor of adverse outcomes in many diseases. However, the prognostic value of Scr/Scys in patients with type 2 diabetes mellitus (T2DM) is unknown. The aim of this study i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Wen, Li, Shanggang, Liu, Jin, Liu, Yong, Chen, Kaihong, Chen, Shiqun, Tu, Mei, Chen, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686100/ https://www.ncbi.nlm.nih.gov/pubmed/36419088 http://dx.doi.org/10.1186/s13098-022-00958-y

Ejemplares similares

Diagnostic and prognostic value of the Creatinine/Cystatin C ratio for low muscle mass evaluation among US adults
por: Shi, Shanshan, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio as a prognostic indicator for patients with colorectal cancer
por: Gao, Shunhui, et al.
Publicado: (2023)

The serum creatinine to cystatin C to waist circumference ratios predicts risk for type 2 diabetes: A Chinese cohort study
por: Chen, Yinfei, et al.
Publicado: (2023)

PB1955: PROGNOSTIC VALUE OF SERUM CREATININE TO CYSTATIN C RATIO AND ESTABLISHMENT OF A NOVEL RISK SCORE MODEL IN CHRONIC LYMPHOCYTIC LEUKEMIA
por: Yin, Zixun, et al.
Publicado: (2023)

Association between the ratio of serum creatinine to cystatin C and bone mineral density in Chinese older adults patients with type 2 diabetes mellitus
por: Gao, Ting, et al.
Publicado: (2022)

Creatinine-to-cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
por: Dai, Huifan, et al.
Publicado: (2022)

Creatinine–cystatin C ratio and mortality in cancer patients: a retrospective cohort study
por: Jung, Chan‐Young, et al.
Publicado: (2022)

Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
por: Dai, Huifang, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer
por: Zheng, Chao, et al.
Publicado: (2022)

Prognostic value of the creatinine-albumin ratio in acute pancreatitis debridement
por: Zhao, Zhifeng, et al.
Publicado: (2020)

Relationship between creatinine to body weight ratios and diabetes mellitus: A Chinese cohort study
por: Chen, Zhuangsen, et al.
Publicado: (2022)

Predictive value of serum creatinine/cystatin C in neurocritically ill patients
por: Wang, Shengnan, et al.
Publicado: (2019)

Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes
por: Hashimoto, Yoshitaka, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer
por: Sun, Jing, et al.
Publicado: (2022)

Elevated urine albumin creatinine ratio increases cardiovascular mortality in coronary artery disease patients with or without type 2 diabetes mellitus: a multicenter retrospective study
por: Lin, Xueqin, et al.
Publicado: (2023)

Comparing the Value of Cystatin C and Serum Creatinine for Evaluating the Renal Function and Predicting the Prognosis of COVID-19 Patients
por: Chen, Sichao, et al.
Publicado: (2021)

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
por: Liu, Hao, et al.
Publicado: (2023)

Spot Urine Albumin to Creatinine Ratio and Serum Cystatin C are Effective for Detection of Diabetic Nephropathy in Childhood Diabetic Patients
por: Chae, Hyun-Wook, et al.
Publicado: (2012)

Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours
por: Ding, Ping’an, et al.
Publicado: (2022)

Prognostic value of troponin/creatinine ratio in patients with chest pain
por: Canbaz, Hayri, et al.
Publicado: (2023)

Utility of serum creatinine/cystatin C ratio in diagnosis of postrenal acute kidney injury
por: İnal, Salih, et al.
Publicado: (2014)

Serum creatinine/cystatin C ratio as a muscle mass evaluating tool and prognostic indicator for hospitalized patients: A meta-analysis
por: Zheng, Wen-He, et al.
Publicado: (2023)

The Ratio of Estimated Glomerular Filtration Rate Based on Cystatin C and Creatinine Reflecting Cardiovascular Risk in Diabetic Patients
por: Khang, Ah Reum, et al.
Publicado: (2023)

Effect of Urinary Albumin Creatinine Ratio on Cardiovascular Morbidity and Mortality in Diabetes Patients with Atherosclerotic Disease
por: Gao, Fei, et al.
Publicado: (2023)

Long-term prognostic impact of cystatin c on acute coronary syndrome octogenarians with diabetes mellitus
por: Fu, Zhenhong, et al.
Publicado: (2013)

Serum creatinine/cystatin C ratio is a predictor of all-cause mortality for older adults over 80 years
por: Zhang, Li, et al.
Publicado: (2023)

Serum Creatinine-to-Cystatin C Ratio in the Progression Monitoring of Non-alcoholic Fatty Liver Disease
por: Li, Shaobo, et al.
Publicado: (2021)

Creatinine and cystatin C: Shooting at a flying target
por: Chao, Chia-Ter
Publicado: (2011)

Age- and sex-specific reference intervals for the serum cystatin C/creatinine ratio in healthy children (0–18 years old)
por: Liu, Changjin, et al.
Publicado: (2019)

Normalized Creatinine-to-Cystatin C Ratio and Risk of Diabetes in Middle-Aged and Older Adults: The China Health and Retirement Longitudinal Study
por: Qiu, Shanhu, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis
por: Fujita, Kohei, et al.
Publicado: (2022)

Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease
por: Hyun, Young Youl, et al.
Publicado: (2022)

Serum creatinine to cystatin C ratio and cognitive function among middle-aged and older adults in China
por: Zhu, Yueli, et al.
Publicado: (2022)

Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease
por: An, Jung Nam, et al.
Publicado: (2022)

The serum creatinine to cystatin C ratio predicts the risk of acute exacerbation of chronic obstructive pulmonary disease
por: He, Liang, et al.
Publicado: (2023)

Serum-Creatinine-to-Cystatin C-to-Waist-Circumference Ratios as an Indicator of Severe Airflow Limitation in Older Adults
por: Li, Jinxuan, et al.
Publicado: (2023)

Estimated GFR With Cystatin C and Creatinine in Clinical Practice: A Retrospective Cohort Study
por: Gottlieb, Eric Raphael, et al.
Publicado: (2023)

The Utility of the Creatinine Excretion to Production Ratio and the Plasma Creatinine and Cystatin C Based Kinetic Estimates of Glomerular Filtration Rates in Critically Ill Patients with Sepsis
por: Md Ralib, Azrina, et al.
Publicado: (2022)

Assessment of microalbuminuria and albumin creatinine ratio in patients with type 2 diabetes mellitus
por: Karar, Tarig, et al.
Publicado: (2015)

Serum Creatinine/Cystatin C Ratio as a Predictor of In-hospital Mortality in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Chen, Zhixiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tui8cjmjg9jipd4t3pso6f52ji